Objective To evaluate the clinical efficacy of Er, Cr: YSGG laser-assisted treatment for peri-implantitis (PI) and to preliminarily explore the differences in the levels of inflammatory factors before and after treatment. Methods This study included 19 patients with peri-implantitis, involving a total of 22 implants, which were randomly divided into three groups. The SRP group received subgingival debridement with a titanium scaler; the SRPL1 group underwent subgingival debridement followed by 1.5 W Er, Cr: YSGG laser-assisted treatment; and the SRPL2 group received subgingival debridement followed by 2.0 W Er, Cr: YSGG laser-assisted treatment. Clinical parameters, including probing depth (PD), modified sulcus bleeding index (mSBI), and modified plaque index (mPLI), were recorded and compared before treatment and 1 and 3 months post-treatment. Peri-implant sulcular fluid was collected for ELISA detection of inflammatory factors, including interleukin (IL)-17, vascular endothelial growth factor (VEGF), and IL-1ra, and the correlations between clinical parameters and inflammatory factors were analyzed. Pain levels were recorded using the visual analogue scale (VAS) at 2 h after treatment. Results All three groups showed significant improvement in PD and mSBI at post-treatment compared to pre-treatment values (P<0.05). However, there was no significant improvement in mPLI, and no differences were observed among the groups (P>0.05). At 1 month post-treatment, both the SRPL1 and SRPL2 groups had significantly lower PD and mSBI values than the SRP group (P<0.05), but no statistically significant difference was found between the SRPL1 and SRPL2 groups (P>0.05). At 3 months post-treatment, only PD was significantly lower in the SRPL1 and SRPL2 groups compared to the SRP group (P<0.05). No significant difference was observed between the two groups (P>0.05). One and three months post-treatment, IL-17 and VEGF levels were significantly reduced (P<0.05). At 1 month post-treatment, compared to the SRP group, the SRPL1 and SRPL2 groups showed a significant decrease in IL-17 and VEGF levels (P<0.05) and a significant increase in IL-1ra levels (P<0.05). At 3 months post-treatment, no significant differences were observed among the three groups (P>0.05). PD were positively correlated with IL-17 and VEGF (P<0.05), while IL-1ra was negatively correlated with PD and mSBI (P>0.05). The VAS scores were significantly higher in the SRP group compared to the SRPL1 and SRPL2 groups (P<0.05). Conclusion Er, Cr: YSGG laser-assisted SRP treatment for peri-implantitis demonstrates excellent clinical outcomes, including improvements in clinical parameters, regulation of inflammatory factor levels, and reduced postoperative pain. The levels of IL-17, VEGF, and IL-1ra in peri-implant sulcular fluid can provide valuable information for the diagnosis, treatment, and evaluation of peri-implantitis.